The NAPACA Outcome Study is part of the ENSAT Registry (https://registry.ensat.org/)
The primary aim of the study is to assess mortality and cardiovascular events potentially linked to cortisol excess in patients with adrenal incidentalomas stratified by cortisol values following the 1-mg overnight dexamethasone test.